Buy Plaquenil (Hydroxychloroquine) 200/400 mg Online

Buy Plaquenil Online

Drug family: Antirheumatic
IN WHAT CASE THE DRUG PLAQUENIL IS PRESCRIBED?
This drug is a slow-acting antirheumatic drug with analgesic and anti-inflammatory properties. Its chemical structure is similar to certain drugs used in the treatment of malaria (anti-malarial drugs).

It is used in the treatment of certain inflammatory rheumatic diseases (rheumatoid arthritis in adults, juvenile idiopathic arthritis in children) and collagen diseases, particularly systemic lupus erythematosus.

It is also used in the prevention of lucites in adults

You can consult the following article(s):

CONTRAINDICATIONS OF THE DRUG PLAQUENIL
This medication should not be used in the following cases:
allergy to chloroquine derivatives (NIVAQUINE...),

retinal disease,

children under 6 years of age,

in association with drugs containing citalopram, escitalopram, hydroxyzine, domperidone or piperaquine,

breast-feeding.

CAUTION
This drug may be toxic to the retina: regular ophthalmological surveillance is essential throughout the treatment. The occurrence of vision problems (changes in visual acuity, color vision, etc.) requires the discontinuation of treatment and prompt ophthalmologic advice.

Hypoglycemia has been observed under treatment. A blood sugar test should be performed in case of signs of hypoglycemia such as: malaise, sweating, palpitations, tremors, paleness.

Hydroxychloroquine may rarely cause heart rhythm disorders. It should be used with caution in cases of hypokalemia, uncontrolled heart failure, recent myocardial infarction, or severe slowing of the heart.

Do not continue treatment without medical advice if an extensive rash appears, with or without fever or lymph nodes: risk of exanthematic pustulosis, rare but potentially serious.

Precautions are necessary in cases of porphyria, renal or hepatic insufficiency, psoriasis and G6PD deficiency.

Regular blood tests are required during prolonged treatment to ensure that there are no abnormalities in the blood count.

Caution: Driver: this drug may cause visual disturbances.

PLAQUENIL INTERACTIONS WITH OTHER SUBSTANCES
This drug should not be combined with drugs containing citalopram, escitalopram, hydroxyzine, domperidone or piperaquine: increased risk of heart rhythm disorders.

It may interact with other drugs that can cause torsades de pointes.

Also tell your doctor if you are taking an anti-epileptic, an anti-diabetic, a drug containing thyroid hormones, ciclosporin or cimetidine.

It is preferable to respect a 2-hour delay between the intake of this medication and that of digestive dressings (containing aluminum, calcium or magnesium salts).

FERTILITY, PREGNANCY AND LACTATION
PREGNANCY:
The effect of this medication during pregnancy is not well known: only your doctor can assess the possible risk of its use in your case.

BREASTFEEDING:
This drug passes into breast milk. Breastfeeding is contraindicated during treatment.

DIRECTIONS FOR USE AND DOSAGE OF PLAQUENIL
The tablets are not suitable for children under 6 years. Indeed, they may obstruct the airways if the child swallows poorly and the tablet passes into the trachea (false route).

They should be swallowed after meals.

USUAL DOSAGE :
Adult:

Treatment of rheumatoid arthritis: 2 or 3 tablets per day in attack treatment, then 1 or 2 tablets per day in maintenance treatment.

In the treatment of lupus erythematosus: initially, 1 to 2 tablets per day until the lesions disappear. The dosage is then gradually reduced.

Prevention of lucites: 2 or 3 tablets per day for 3 weeks, starting the treatment 7 days before exposure.

Children over 6 years of age (weighing more than 31 kg): the minimum effective dose is sought by the physician and should not exceed 6.5 mg per kg per day.

POSSIBLE SIDE EFFECTS OF PLAQUENIL
Very common (more than 10% of cases): abdominal pain, nausea.

Common (1-10% of cases): diarrhea, vomiting, loss of appetite, headache, itching, rash, accommodation disorders (blurred vision)

Uncommon (less than 1% of cases): dark discoloration, especially of nails and mucous membranes, hair loss or discoloration, nervousness, dizziness, ringing in the ears, deposition of drug in the cornea which may result in halos or light intolerance, retinal disease which regresses on discontinuation of treatment, increased transaminases.

Unknown: potentially severe bullous rash, muscle weakness, heart rhythm disturbances, heart failure, abnormal movements, tremors, seizures, hypokalemia, porphyria crisis, abnormal blood count, allergic reaction (hives, bronchospasm, angioedema)

If you have experienced an adverse reaction that may be due to this medication, you can report it online.